[Expert consensus on the prevention and treatment of multiple myeloma related venous thromboembolism in China (2022)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):726-731. doi: 10.3760/cma.j.issn.0253-2727.2022.09.003.
Abstract
摘要
相似文献
1
[Expert consensus on the prevention and treatment of multiple myeloma related venous thromboembolism in China (2022)].
Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):726-731. doi: 10.3760/cma.j.issn.0253-2727.2022.09.003.
2
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
J Thromb Thrombolysis. 2021 Aug;52(2):584-589. doi: 10.1007/s11239-020-02354-7. Epub 2021 Jan 8.
3
Prevention of VTE in multiple myeloma patients.
Thromb Res. 2007;120 Suppl 2:S133-6. doi: 10.1016/S0049-3848(07)70142-1.
4
Thromboprophylaxis in multiple myeloma.
Leuk Lymphoma. 2022 Dec;63(12):2807-2815. doi: 10.1080/10428194.2022.2092856. Epub 2022 Jun 27.
5
Myeloma and thrombotic complications.
Minerva Med. 2013 Apr;104(2):155-60.
6
Updates on thrombotic events associated with multiple myeloma.
Expert Rev Hematol. 2019 May;12(5):355-365. doi: 10.1080/17474086.2019.1604214. Epub 2019 Apr 14.
7
[Newly diagnosed multiple myeloma: Do we need to propose thromboprophylaxis?].
Rev Med Interne. 2012 Dec;33(12):693-6. doi: 10.1016/j.revmed.2012.05.006. Epub 2012 Oct 12.
8
Association between cancer types, cancer treatments, and venous thromboembolism in medical oncology patients.
Clin Adv Hematol Oncol. 2013 Jun;11(6):349-57.
9
Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations.
Br J Haematol. 2018 Nov;183(4):538-556. doi: 10.1111/bjh.15684. Epub 2018 Nov 18.
10
Venous thromboembolism in patients with myeloma: incidence and risk factors in a "real-world" population.
Clin Appl Thromb Hemost. 2014 Sep;20(6):600-6. doi: 10.1177/1076029614521280. Epub 2014 Jan 30.
引用本文的文献
1
[Chinese expert consensus on standard procedures for the outpatient management of patients with multiple myeloma (2025)].
Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):284-288. doi: 10.3760/cma.j.cn121090-20250123-00044.
本文引用的文献
1
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
J Natl Compr Canc Netw. 2022 Jan;20(1):8-19. doi: 10.6004/jnccn.2022.0002.
2
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis.
Br J Haematol. 2022 Jan;196(1):105-109. doi: 10.1111/bjh.17772. Epub 2021 Aug 15.
3
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study.
J Cancer Res Clin Oncol. 2022 Apr;148(4):975-984. doi: 10.1007/s00432-021-03693-5. Epub 2021 Jun 18.
4
Venous thromboembolism.
Lancet. 2021 Jul 3;398(10294):64-77. doi: 10.1016/S0140-6736(20)32658-1. Epub 2021 May 10.
5
Venous thromboembolism in patients with multiple myeloma receiving daratumumab-based regimens: a analysis of phase 3 clinical trials.
Leuk Lymphoma. 2021 Sep;62(9):2219-2226. doi: 10.1080/10428194.2021.1910687. Epub 2021 Apr 9.
6
Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis.
Int J Hematol. 2020 Nov;112(5):650-657. doi: 10.1007/s12185-020-02954-2. Epub 2020 Jul 24.
7
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials.
Blood. 2020 Aug 27;136(9):1091-1104. doi: 10.1182/blood.2020005125.
8
Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools.
Cancers (Basel). 2020 Jan 13;12(1):191. doi: 10.3390/cancers12010191.
9
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.
Am J Hematol. 2019 Nov;94(11):1176-1184. doi: 10.1002/ajh.25603. Epub 2019 Aug 19.
10
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma.
J Natl Compr Canc Netw. 2019 Jul 1;17(7):840-847. doi: 10.6004/jnccn.2018.7273.
Zotero 插件